⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Apo(a)-Rich Electronegative HDL (H5) in Vascular Aging
Current understanding
The most electronegative HDL subfraction (H5), enriched in apolipoprotein(a), is proposed as a pro-atherogenic ‘dysfunctional HDL’ species that induces endothelial senescence via the p53–p21 axis and associates with carotid IMT and plaque in CVD-risk cohorts [human-observational, mechanism-plausible]. Reframes HDL biology from a quantity (HDL-C) to a quality/subfraction story upstream of vascular aging, with translation limited to cross-sectional human associations plus in-vitro/in-vivo mechanism.
Evidence log
- 2026-09-09 — Apolipoprotein(a)-rich electronegative HDL accelerates vascular aging and atherosclerosis by inducing endothelial senescence.: cross-connection with vsmc-plasticity-atherosclerosis: H5-driven endothelial senescence sits upstream of the atherosclerotic milieu in which VSMC phenotypic switching occurs; both are candidate nodes in the same plaque-biology network. (novelty: 3)
Open questions
Related
Contributing findings
Apolipoprotein(a)-rich electronegative HDL accelerates vascular aging and atherosclerosis by inducing endothelial senescence.
09-sep-2026
novelty 3
per-area 3
introduces